{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:48:07Z","timestamp":1790812087874,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI052453"],"award-info":[{"award-number":["R01 AI052453"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR052728"],"award-info":[{"award-number":["R01 AR052728"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/jid.2012.14","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T09:29:10Z","timestamp":1329384550000},"page":"1435-1442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin"],"prefix":"10.1016","volume":"132","author":[{"given":"Kimberly N.","family":"Kanada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruaki","family":"Nakatsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2012.14_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1515\/bc.2010.055","article-title":"Interdependence of kallikrein-related peptidases in proteolytic networks","volume":"391","author":"Beaufort","year":"2010","journal-title":"Biol Chem"},{"key":"10.1038\/jid.2012.14_bb0015","first-page":"109","article-title":"[Blood and tissue levels of 2 antibiotics of the tetracycline group orally administered to man]","volume":"6","author":"Belli","year":"1968","journal-title":"Antibiotica"},{"key":"10.1038\/jid.2012.14_bb0020","doi-asserted-by":"crossref","first-page":"30033","DOI":"10.1074\/jbc.274.42.30033","article-title":"Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation","volume":"274","author":"Brattsand","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.14_bb0025","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome","volume":"206","author":"Briot","year":"2009","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2012.14_bb0030","first-page":"18","article-title":"Concentrations of doxycycline in muscle tissue and muscle tissue fluid","volume":"53","author":"Cars","year":"1988","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1038\/jid.2012.14_bb0035","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.0022-202X.2004.22512.x","article-title":"Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE\/KLK5\/hK5 and SCCE\/KLK7\/hK7","volume":"122","author":"Caubet","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.14_bb0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/0022034510366903","article-title":"Cleavage site specificity of MMP-20 for secretory-stage ameloblastin","volume":"89","author":"Chun","year":"2010","journal-title":"J Dent Res"},{"key":"10.1038\/jid.2012.14_bb0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells","volume":"192","author":"De","year":"2000","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2012.14_bb0050","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2012.14_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/000155500750012513","article-title":"Desquamation in the stratum corneum","volume":"208","author":"Egelrud","year":"2000","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1038\/jid.2012.14_bb0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1074\/jbc.M110.125310","article-title":"Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade","volume":"286","author":"Eissa","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.14_bb0065","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1124\/mol.104.006346","article-title":"Molecular interactions between matrilysin and the matrix metalloproteinase inhibitor doxycycline investigated by deuterium exchange mass spectrometry","volume":"67","author":"Garcia","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1038\/jid.2012.14_bb0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/08959374980120010501","article-title":"Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms","volume":"12","author":"Golub","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1038\/jid.2012.14_bb0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-051X.1995.tb00120.x","article-title":"Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva","volume":"22","author":"Golub","year":"1995","journal-title":"J Clin Periodontol"},{"key":"10.1038\/jid.2012.14_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/08959374980120010301","article-title":"Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells","volume":"12","author":"Hanemaaijer","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1038\/jid.2012.14_bb0085","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.0022-202X.2004.23583.x","article-title":"LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum","volume":"124","author":"Ishida-Yamamoto","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.14_bb0090","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2010.03825.x","article-title":"Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea","volume":"25","author":"Jang","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/jid.2012.14_bb0095","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1074\/jbc.M110.191361","article-title":"Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma","volume":"286","author":"Jiang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.14_bb0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0625.1997.tb00164.x","article-title":"Matrix metalloproteinases in skin","volume":"6","author":"Kahari","year":"1997","journal-title":"Exp Dermatol"},{"key":"10.1038\/jid.2012.14_bb0105","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0002-9440(10)62479-0","article-title":"Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo","volume":"166","author":"Kang","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2012.14_bb0110","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.peptides.2011.03.009","article-title":"Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6","volume":"32","author":"Kantyka","year":"2011","journal-title":"Peptides"},{"key":"10.1038\/jid.2012.14_bb0115","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2012.14_bb0120","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1468-3083.2009.03167.x","article-title":"Current topical and systemic approaches to treatment of rosacea","volume":"23","author":"Korting","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/jid.2012.14_bb0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000235550","article-title":"Tetracycline actions relevant to rosacea treatment","volume":"22","author":"Korting","year":"2009","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1038\/jid.2012.14_bb0130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1038\/jid.2012.14_bb0135","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1128\/iai.63.4.1291-1297.1995","article-title":"Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein","volume":"63","author":"Larrick","year":"1995","journal-title":"Infect Immun"},{"key":"10.1038\/jid.2012.14_bb0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/1380-2933(95)00006-2","article-title":"Anti-microbial activity of human CAP18 peptides","volume":"1","author":"Larrick","year":"1995","journal-title":"Immunotechnology"},{"key":"10.1038\/jid.2012.14_bb0145","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1167\/iovs.04-0299","article-title":"Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells","volume":"45","author":"Li","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/jid.2012.14_bb0150","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00018-008-8024-3","article-title":"Kallikrein-related peptidases","volume":"65","author":"Lundwall","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1038\/jid.2012.14_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.bmb.a070338","article-title":"Epsilon-aminocaproic acid and other inhibitors of fibrinolysis","volume":"20","author":"McNicol","year":"1964","journal-title":"Br Med Bull"},{"key":"10.1038\/jid.2012.14_bb0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00005-009-0045-6","article-title":"Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases","volume":"57","author":"Meyer-Hoffert","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1038\/jid.2012.14_bb0165","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1074\/jbc.M408132200","article-title":"Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression","volume":"280","author":"Michael","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.14_bb0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.phrs.2010.10.007","article-title":"Clinical applications of non-antimicrobial tetracyclines in dermatology","volume":"63","author":"Monk","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1038\/jid.2012.14_bb0175","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/jid.2009.435","article-title":"Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid","volume":"130","author":"Morizane","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.14_bb0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1515\/bc.2010.023","article-title":"Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation","volume":"391","author":"Ohler","year":"2010","journal-title":"Biol Chem"},{"key":"10.1038\/jid.2012.14_bb0185","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2012.14_bb0190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/jid.2008.320","article-title":"Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37","volume":"129","author":"Park","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.14_bb0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/jidsymp.2009.8","article-title":"Matrix-degrading metalloproteinases in photoaging","volume":"14","author":"Quan","year":"2009","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2012.14_bb0200","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1034\/j.1600-0722.2002.21349.x","article-title":"Porcine kallikrein-4 activation, glycosylation, activity, and expression in prokaryotic and eukaryotic hosts","volume":"110","author":"Ryu","year":"2002","journal-title":"Eur J Oral Sci"},{"key":"10.1038\/jid.2012.14_bb0205","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.629","article-title":"Matriptase initiates epidermal prokallikrein activation and disease onset in a mouse model of Netherton syndrome","volume":"42","author":"Sales","year":"2010","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2012.14_bb0210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00105-007-1457-z","article-title":"[Cathelicidin LL-37. A central factor in the pathogenesis of inflammatory dermatoses?]","volume":"59","author":"Schauber","year":"2008","journal-title":"Hautarzt"},{"key":"10.1038\/jid.2012.14_bb0215","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.14_bb0220","doi-asserted-by":"crossref","first-page":"32989","DOI":"10.1074\/jbc.R109.027946","article-title":"Functional roles of human kallikrein-related peptidases","volume":"284","author":"Sotiropoulou","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.14_bb0225","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1515\/BC.2006.095","article-title":"Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum","volume":"387","author":"Stefansson","year":"2006","journal-title":"Biol Chem"},{"key":"10.1038\/jid.2012.14_bb0230","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.1994.tb24731.x","article-title":"Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes","volume":"732","author":"Uitto","year":"1994","journal-title":"Ann NY Acad Sci"},{"key":"10.1038\/jid.2012.14_bb0235","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2133.2009.09142.x","article-title":"Increased stratum corneum serine protease activity in acute eczematous atopic skin","volume":"161","author":"Voegeli","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2012.14_bb0240","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0002-9440(10)63026-X","article-title":"A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness","volume":"159","author":"Wolf","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2012.14_bb0245","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"10.1038\/jid.2012.14_bb0250","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","article-title":"Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin","volume":"20","author":"Yamasaki","year":"2006","journal-title":"FASEB J"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15357444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15357444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:53:52Z","timestamp":1743962032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15357444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0022202X15357444"],"URL":"https:\/\/doi.org\/10.1038\/jid.2012.14","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2012.14","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}